FGFR3 overexpression results in the activation of the transcription factor STAT3 and consequent upregulation of its target BCLXL gene, which is functioning in suppressing apoptosis and promoting MM development [487]. The gene discussed is STAT3; the disease is Miyoshi myopathy.